皇家飞利浦获得SpetraWAVE 来提升人工智能心脏成像和血液流动分析。 Royal Philips acquires SpectraWAVE to boost AI-powered heart imaging and blood flow analysis.

菲利普斯皇家公司已同意收购SpectraWAVE Inc., 一家总部位于马萨诸塞州的医疗技术公司, Royal Philips has agreed to acquire SpectraWAVE Inc., a Massachusetts-based medical tech company, to enhance its coronary imaging and physiology tools. 协议包括SpetraWAVEVE的超VueTM成像系统和X1TM-FFR、提供详细动脉成像的AI动力技术以及单一血管成像的血液流量评估。 The deal includes SpectraWAVE’s HyperVue™ Imaging System and X1™-FFR, AI-powered technologies that provide detailed artery imaging and blood flow assessment from a single angiogram. 购买的目的是通过将这些工具与菲利普的Azurion平台相结合,改善冠动脉疾病这一全球主要心脏病的诊断和治疗。 The acquisition aims to improve diagnosis and treatment of coronary artery disease, a leading global heart condition, by integrating these tools with Philips’ Azurion platform. 此举支持Philips扩大AI驱动的心脏护理战略, 改善最低侵入性手术的结果。 The move supports Philips’ strategy to expand AI-driven cardiac care and improve outcomes in minimally invasive procedures.